Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.55 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CDC25B | P30305 | 1/20 | 0.40 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.40 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.40 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.40 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.32 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.32 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.32 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19807196 | 0.80 | PIM1 (0.69) | PIM1AURKACYP1A1CYP1A2CDC25B | |
| SCHEMBL19798280 | 0.78 | PIM1 (0.61) | PIM1AURKACYP1A1CYP1A2CDC25B | |
| SCHEMBL25139350 | 0.72 | ESR1 (0.46) | — | |
| SCHEMBL19954364 | 0.71 | ELANE (0.49) | — | |
| SCHEMBL22876775 | 0.69 | ELANE (0.39) | — | |
| SCHEMBL19798278 | 0.68 | PIM1 (0.73) | PIM1AURKACYP1A1CYP1A2CDC25B | |
| SCHEMBL23808373 | 0.68 | ELANE (0.51) | — | |
| SCHEMBL17265615 | 0.66 | PIM1 (0.66) | PIM1AURKACYP1A1CYP1A2CDC25B | |
| SCHEMBL19901519 | 0.66 | POLB (0.44) | — | |
| SCHEMBL18487391 | 0.66 | MAPT (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230123203-A1 | METHOD FOR PRODUCING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, METHOD FOR PRODUCING ELECTRONIC DEVICE, AND METHOD FOR PRODUCING ONIUM SALT | FUJIFILM CORPORATION (JP) | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230123203-A1 | METHOD FOR PRODUCING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, METHOD FOR PRODUCING ELECTRONIC DEVICE, AND METHOD FOR PRODUCING ONIUM SALT | PRKAR2B, GRK7, PRKAR2A | PIM1 2731/4885AURKA 3281/4885CYP1A1 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.